January 08, 2025 04:33 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad

WHO recommends COVID-19 drug and urges transparency around pricing

Apr 22, 2022, at 11:28 pm

New York: A highly successful COVID-19 therapy must be made available to more people, the World Health Organization (WHO) has said, calling for wider distribution and greater transparency surrounding its pricing.

UK testing new drug to prevent COVID-19 development after Coronavirus contraction: Reports

Dec 26, 2020, at 02:33 pm

Moscow/Sputnik: UK scientists are testing a new drug to prevent people, who have been exposed to the coronavirus, from falling ill with COVID-19, media reported.  

Facebook removes video about COVID-19 drug from RT Arabic's official page

Jul 20, 2020, at 09:55 pm

Moscow/Sputnik: Facebook has removed a video about a drug against the coronavirus from the official account of the RT Arabic broadcaster.

Eli Lilly commences study of a potential COVID-19 antibody treatment in humans

Jun 02, 2020, at 05:24 pm

Indianapolis/IBNS: Eli Lilly and Company on Monday announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.

Glenmark to start new Phase 3 clinical trial on a combination of two anti-viral drugs in hospitalized patients of moderate COVID-19 in India

May 27, 2020, at 12:59 am

Mumbai/IBNS: Glenmark Pharmaceuticals, a pharmaceutical company, has announced a new randomized, open-label study to test thecombined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19treatment strategy.